Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease-Reference-Cited by-同舟云学术

Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease

Published:2022-12 Issue: Volume:156 Page:113908
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Shin Jeong-Yong,Lee Bina,Ham Sangwoo,Kim Ji Hun,Kim Hyojung,Kim Heejeong,Jo Min Gi,Kim Hye Jung,Park Sang Won^ORCID,Kweon Hee-Seok,Kim Yong Jun,Yun Seung Pil,Lee Yunjong^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference34 articles.

1. Parkinson's disease. Second of two parts;Lang;N. Engl. J. Med,1998

2. Parkinson's disease. First of two parts;Lang;N. Engl. J. Med,1998

3. Staging of brain pathology related to sporadic Parkinson's disease;Braak;Neurobiol. Aging,2003

4. Activation of tyrosine kinase c-Abl contributes to alpha-synuclein-induced neurodegeneration;Brahmachari;J. Clin. Invest,2016

5. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice;Lee;Proc. Natl. Acad. Sci. USA,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AIMP2 restricts EV71 replication by recruiting SMURF2 to promote the degradation of 3D polymerase;Virologica Sinica;2024-08

2. The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity;Science Advances;2024-04-05

3. Protein–protein interactions regulating α-synuclein pathology;Trends in Neurosciences;2024-03

4. Protein-protein interactions regulating α-synuclein pathology;TRENDS NEUROSCI;2024

5. A2-astrocyte activation by short term hypoxia rescue α-synuclein preformed fibril induced neuronal cell death;2024-02-08